Sara E. Sacher1, John P. Neri1, Madeleine A. Gao1, Hollis G. Potter1, and Matthew F. Koff1
1Department of Radiology, Hospital for Special Surgery, New York, NY, United States
Synopsis
The infrapatellar fat pad (IPFP) has been implicated as a source of pain
after total knee arthroplasty (TKA), but regions close to metallic implants are
susceptible to metal artifacts in MRI. Multi-acquisition variable-resonance image
combination (MAVRIC) based T2 mapping technique can mitigate these artifacts.
The goal of this study was to evaluate how T2 values of the IPFP vary with the
degree of IPFP scarring. T2 values were shorter and displayed a wider range for individuals with more severe scarring. MAVRIC T2
mapping may be used as a quantitative biomarker of IPFP scarring.
Introduction
Over 600,000 total knee arthroplasties (TKAs) are performed annually in
the US as of 2010, and this number is expected to increase exponentially.1 The infrapatellar fat pad (IPFP) has been
implicated as a possible source of postoperative knee pain due to its
substantial innervation and proximity to the synovial lining.2–4 TKA surgery can lead to chronic inflammation of
the IPFP, which over time can develop into scar tissue.5 T2 mapping, a quantitative magnetic resonance
(qMRI) technique, has been used to evaluate the IPFP in patients following
anterior cruciate ligament reconstruction ,3 but its application to TKA patients is
challenging due to the presence of metallic susceptibility artifact when using
traditional fast-spin-echo based imaging techniques.6 Multi-acquisition variable-resonance (MAVRIC)
based T2 mapping technique has been developed to mitigate these artifacts,
allowing for enhanced detection of soft tissue around implants.7 How T2 values of the IPFP relate to IPFP
scarring is currently unknown. Therefore, the objective of this study was to
measure T2 values of the IPFP in patients with TKAs using a MAVRIC based T2
mapping technique and to determine if T2 values are related to the degree of
IPFP scarring.Methods
This pilot study had local IRB approval and informed written consent was
obtained. 22 patients with TKAs undergoing MRIs were sequentially recruited and
scanned on clinical 1.5T scanners with an 8-channel phased-array knee coil (GE
Healthcare, Waukesha, WI). Morphologic imaging8 and MAVRIC based T2 mapping images9 were acquired. The morphologic images were
evaluated for the presence (present/not present) and global severity of fat pad
scarring by a board-certified radiologist as: none, mild, moderate or severe.
The full volume of the IPFP, as well as smaller defined regions of normal (3.4
mm3) and abnormal (3.4 mm3) IPFP regions were segmented from
source T2 mapping images by the radiologist. T2 values in these regions were
calculated on a pixel-by-pixel basis with a mono-exponential fit. Statistical
Analysis: A one-way ANOVA was performed to evaluate differences of full volume
IPFP T2 values by severity of fat pad scarring, with Tukey-adjusted post hoc
comparisons to compare T2 values between groups. Paired t-tests were also
performed to compare mean T2 values in the normal vs. abnormal regions within
all subjects. In addition, the difference of mean T2 values between normal and
abnormal subregions within each subject was calculated and evaluated across the
level of IPFP scarring severity with a one-way ANOVA and appropriate post hoc
comparisons. Finally, one-way ANOVAS with Tukey-adjusted post hoc comparisons
were performed to evaluate differences of mean normal and abnormal region T2
values by severity of fat pad scarring. A significance level of p<0.05 was
used for all analyses.Results
Mean full volume IPFP T2 values were shorter in patients with severe
scarring as compared to those with mild scarring (23% reduction, p = 0.002,
Figures 1, 2). T2 values were reduced in abnormal regions vs. normal regions
within subjects (p < 0.0001). The difference between T2 values in abnormal
regions vs. normal regions was greater in patients with severe scarring vs.
patients with no scarring (551% increase, p = 0.032, Figure 3). The subregional
analysis of the IPFP found that T2 values from the abnormal regions were
significantly shorter in patients with global moderate and severe scarring as
compared to patients with no global scarring (None vs. Moderate: 39% reduction,
p = 0.028, None vs. Severe: 43% reduction, p = 0.007, Figure 4). No differences
between T2 values in the normal regions between subjects were found.Discussion
This study evaluated the difference in T2 values of the IPFP with the
degree of IPFP scarring in TKA patients using a MAVRIC based T2 mapping
technique. This preliminary evaluation found significantly shorter global IPFP
T2 values in patients with severe IPFP scarring, as compared to those with
normal or mild scarring. These results are in line with previous findings of
shorter IPFP T2 values associated with fibrosis found in knees following
arthroscopic surgery.3 Reduced T2 values may be explained by increased
tissue organization due to scar formation with lower tissue water content.3,10 Notably, the greater difference between T2
values of abnormal regions vs. normal regions in individuals with severe
scarring compared to those with normal tissue may indicate increased tissue
heterogeneity in the IPFP with increased scarring severity. Limitations of this
study include limited patient enrollment and assessment of scarring on
morphologic imaging without histological confirmation. Future work may include
histological correlation following revision and patient-reported clinical
outcomes. These results demonstrate the feasibility of using MAVRIC based T2
mapping to quantitatively evaluate post-arthroplasty IPFP scarring and fibrosis
in individuals with TKAs.Significance/Clinical Relevance
MAVRIC based T2 Mapping may be used as a quantitative
biomarker of post-operative IPFP scarring in patients following TKA.
Longitudinal monitoring of IPFP T2 values may provide a means to assess the
development and progression of IPFP scarring, a known complication following
TKA implantation.Acknowledgements
Research reported in
this abstract was partially supported by NIH/NIAMS under award number R01AR064840.References
1. Singh, J.
A., Yu, S., Chen, L. & Cleveland, J. D. Rates of total joint replacement in
the United States: Future projections to 2020-2040 using the national inpatient
sample. J. Rheumatol. 46, 1134–1140 (2019).
2. Dragoo, J.
L., Johnson, C. & McConnell, J. Evaluation and treatment of disorders of
the infrapatellar fat pad. Sport. Med. 42, 51–67 (2012).
3. Torriani,
M. et al. T2 relaxometry of the infrapatellar fat pad after arthroscopic
surgery. Skeletal Radiol. 43, 315–321 (2014).
4. Maculé, F.,
Sastre, S., Lasurt, S., Sala, P., Segur, J.-M., Mallofré, C. Hoffa’s fat pad
resection in total knee arthroplasty. Acta Orthop. Belg. 71,
714–717 (2005).
5. Murakami,
S., Muneta, T., Ezura, Y., Furuya, K. & Yamamoto, H. Quantitative analysis
of synovial fibrosis in the infrapatellar fat pad before and after anterior
cruciate ligament reconstruction. Am. J. Sports Med. 25, 29–34
(1997).
6. Hargreaves,
B. A. et al. Metal-induced artifacts in MRI. Am. J. Roentgenol. 197,
547–555 (2011).
7. Cheung, J. et
al. Clinical Feasibility of Multi-Acquisition Variable-Resonance Image
Combination–Based T2 Mapping near Hip Arthroplasty. HSS J. 17,
165–173 (2021).
8. Li, A. E. et
al. MRI for the preoperative evaluation of femoroacetabular impingement. Insights
Imaging 7, 187–198 (2016).
9. Bhave, S.,
Koff, M. F., Sivaram Kaushik, S., Potter, H. G. & Koch, K. M.
3D-multi-spectral T2 mapping near metal implants. Magn. Reson. Med. 82,
614–621 (2019).
10. Cameron, I.
L., Ord, V. A. & Fullerton, G. D. Characterization of proton NMR relaxation
times in normal and pathological tissues by correlation with other tissue
parameters. Magn. Reson. Imaging 2, 97–106 (1984).